Besides direct cancer cell killing, the engagement of effector lymphocytes CD8+ T, CD4+ T, and NKT cells and the presence of associated proinflammatory molecules in the TME suggests that TILT-517 efficiently triggered elements of innate and adaptive immune response. This evidence concerns the gene CD8A and cancer.